$1.13
-0.05-4.24%
Ult. Agg.: Oct 26, 7:18 AM
Bionano Genomics (BNGO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Bionano Genomics (BNGO) ha pubblicato l'ultima guidance il agosto 10, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $31M - $33M per il periodo.
Rispetto alle previsioni precedenti, Bionano Genomics ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Bionano Genomics ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Bionano Genomics. 36
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.68 | $-0.92 | $-2.81 | $-2.13 |
| Actual | $-0.64 | $-0.76 | $-0.77 | $-1.59 |
| Surprise | +5.88% | +17.4% | +72.6% | +25.4% |
| Revenue | ||||
| Estimate | $7.5M | $6.6M | $7.9M | $6.9M |
| Actual | $8.2M | $6.7M | $8.0M | $7.4M |
| Surprise | +9.30% | +2.03% | +0.80% | +7.33% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.47 | $-0.41 |
| Revenue | ||
| Consensus | $8.4M | $9.4M |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.64 | $-0.68 | 5.88 % |
| Q1 | May 13, 2026 | $-0.76 | $-0.92 | 17.4 % |
| Q4 | Mar 23, 2026 | $-0.77 | $-2.81 | 72.6 % |
| Q3 | Nov 13, 2025 | $-1.59 | $-2.13 | 25.4 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $8.17M | $7.48M | 9.30 % |
| Q1 | May 13, 2026 | $6.69M | $6.55M | 2.03 % |
| Q4 | Mar 23, 2026 | $7.95M | $7.89M | 0.80 % |
| Q3 | Nov 13, 2025 | $7.37M | $6.86M | 7.33 % |